Literature DB >> 18711748

Genetic disruption of cyclooxygenase-2 does not improve histological or behavioral outcome after traumatic brain injury in mice.

Muzamil Ahmad1, Marie E Rose, Vincent Vagni, Raymond P Griffith, C Edward Dixon, Patrick M Kochanek, Robert W Hickey, Steven H Graham.   

Abstract

Increasing evidence suggests a role for cyclooxygenase-2 (COX-2) in traumatic brain injury (TBI). In the present study, the role of COX-2 in TBI was investigated using COX-2 gene-disrupted (COX-2 null) mice and wild-type (WT) controls that were subjected to the controlled cortical impact (CCI) model of TBI. There was increased expression of COX-2 in ipsilateral hippocampus in WT mice subjected to CCI. CCI resulted in a significant increase in prostaglandin E(2) concentrations in WT compared with COX-2 null hippocampi. There was a significant increase in TUNEL staining of CA1 neurons 24 hr after CCI in WT, but not in COX-2 null mice, compared with sham-operated controls, which is consistent with a protective role for COX-2 in the early phase of injury after TBI. However, there was no difference in lesion volume 21 days after CCI in COX-2 null and WT mice. COX-2 gene disruption did not alter Morris water maze performance. Taken together, these results suggest only a minor role for COX-2 activity in determining outcome after TBI in mouse. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18711748      PMCID: PMC2737709          DOI: 10.1002/jnr.21809

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  48 in total

1.  Inhibition of cyclooxygenase 2 by nimesulide decreases prostaglandin E2 formation but does not alter brain edema or clinical recovery after closed head injury in rats.

Authors:  L Koyfman; J Kaplanski; A A Artru; D Talmor; M Rubin; Y Shapira
Journal:  J Neurosurg Anesthesiol       Date:  2000-01       Impact factor: 3.956

Review 2.  Lipoxins and new lipid mediators in the resolution of inflammation.

Authors:  Jan M Schwab; Charles N Serhan
Journal:  Curr Opin Pharmacol       Date:  2006-06-05       Impact factor: 5.547

3.  Traumatic injury induces differential expression of cell death genes in organotypic brain slice cultures determined by complementary DNA array hybridization.

Authors:  B Morrison; J H Eberwine; D F Meaney; T K McIntosh
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

4.  Transgenic mice that overexpress the anti-apoptotic Bcl-2 protein have improved histological outcome but unchanged behavioral outcome after traumatic brain injury.

Authors:  Roya Tehranian; Marie E Rose; Vincent Vagni; R P Griffith; Shasha Wu; Sara Maits; Xiaopeng Zhang; Robert S B Clark; C Edward Dixon; Patrick M Kochanek; Ora Bernard; Steven H Graham
Journal:  Brain Res       Date:  2006-06-19       Impact factor: 3.252

5.  Regional expression and role of cyclooxygenase-2 following experimental traumatic brain injury.

Authors:  P K Dash; S A Mach; A N Moore
Journal:  J Neurotrauma       Date:  2000-01       Impact factor: 5.269

6.  Celecoxib after the onset of reperfusion reduces apoptosis in the amygdala.

Authors:  Sévan Kaloustian; Boubacar P Wann; Thierno M Bah; Stéphanie Falcao; Anne-Marie Dufort; Philippe Ryvlin; Roger Godbout; Guy Rousseau
Journal:  Apoptosis       Date:  2007-11       Impact factor: 4.677

7.  Autophagy is increased after traumatic brain injury in mice and is partially inhibited by the antioxidant gamma-glutamylcysteinyl ethyl ester.

Authors:  Yichen Lai; Robert W Hickey; Yaming Chen; Hülya Bayir; Mara L Sullivan; Charleen T Chu; Patrick M Kochanek; C Edward Dixon; Larry W Jenkins; Steven H Graham; Simon C Watkins; Robert S B Clark
Journal:  J Cereb Blood Flow Metab       Date:  2007-09-05       Impact factor: 6.200

8.  Soluble epoxide hydrolase: a novel therapeutic target in stroke.

Authors:  Wenri Zhang; Ines P Koerner; Ruediger Noppens; Marjorie Grafe; Hsing-Ju Tsai; Christophe Morisseau; Ayala Luria; Bruce D Hammock; John R Falck; Nabil J Alkayed
Journal:  J Cereb Blood Flow Metab       Date:  2007-04-18       Impact factor: 6.200

9.  Cyclooxygenase-2 activity following traumatic brain injury in the developing rat.

Authors:  Robert W Hickey; P David Adelson; Michael J Johnnides; Dwight S Davis; Zhisheng Yu; Marie E Rose; Yue-Fang Chang; Steven H Graham
Journal:  Pediatr Res       Date:  2007-09       Impact factor: 3.756

10.  Differential gene expression patterns in cyclooxygenase-1 and cyclooxygenase-2 deficient mouse brain.

Authors:  Christopher D Toscano; Vinaykumar V Prabhu; Robert Langenbach; Kevin G Becker; Francesca Bosetti
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  12 in total

1.  The cyclooxygenase site, but not the peroxidase site of cyclooxygenase-2 is required for neurotoxicity in hypoxic and ischemic injury.

Authors:  Wenjin Li; Shasha Wu; Muzamil Ahmad; Jianfei Jiang; Hao Liu; Tetsuya Nagayama; Marie E Rose; Vladimir A Tyurin; Yulia Y Tyurina; Grigory G Borisenko; Natalia Belikova; Jun Chen; Valerian E Kagan; Steven H Graham
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

Review 2.  Bridge between neuroimmunity and traumatic brain injury.

Authors:  Matthew L Kelso; Howard E Gendelman
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 3.  The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research.

Authors:  Sang-Ho Choi; Saba Aid; Francesca Bosetti
Journal:  Trends Pharmacol Sci       Date:  2009-03-09       Impact factor: 14.819

4.  The brain in vivo expresses the 2',3'-cAMP-adenosine pathway.

Authors:  Jonathan D Verrier; Travis C Jackson; Rashmi Bansal; Patrick M Kochanek; Ava M Puccio; David O Okonkwo; Edwin K Jackson
Journal:  J Neurochem       Date:  2012-03-20       Impact factor: 5.372

5.  Severe brief pressure-controlled hemorrhagic shock after traumatic brain injury exacerbates functional deficits and long-term neuropathological damage in mice.

Authors:  Joseph N Hemerka; Xianren Wu; C Edward Dixon; Robert H Garman; Jennifer L Exo; David K Shellington; Brian Blasiole; Vincent A Vagni; Keri Janesko-Feldman; Mu Xu; Stephen R Wisniewski; Hülya Bayır; Larry W Jenkins; Robert S B Clark; Samuel A Tisherman; Patrick M Kochanek
Journal:  J Neurotrauma       Date:  2012-08-10       Impact factor: 5.269

6.  Animal Models of Posttraumatic Seizures and Epilepsy.

Authors:  Alexander V Glushakov; Olena Y Glushakova; Sylvain Doré; Paul R Carney; Ronald L Hayes
Journal:  Methods Mol Biol       Date:  2016

7.  Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury.

Authors:  Fengshan Yu; Zhifei Wang; Flaubert Tchantchou; Chi-Tso Chiu; Yumin Zhang; De-Maw Chuang
Journal:  J Neurotrauma       Date:  2011-11-01       Impact factor: 5.269

8.  Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury.

Authors:  Flaubert Tchantchou; Yumin Zhang
Journal:  J Neurotrauma       Date:  2013-04-05       Impact factor: 5.269

Review 9.  Non-Steroidal Anti-Inflammatory Drugs in Alzheimer's Disease and Parkinson's Disease: Reconsidering the Role of Neuroinflammation.

Authors:  Amy H Moore; Matthew J Bigbee; Grace E Boynton; Colin M Wakeham; Hilary M Rosenheim; Christopher J Staral; James L Morrissey; Amanda K Hund
Journal:  Pharmaceuticals (Basel)       Date:  2010-06-02

10.  Effects of genetic deficiency of cyclooxygenase-1 or cyclooxygenase-2 on functional and histological outcomes following traumatic brain injury in mice.

Authors:  Matthew L Kelso; Stephen W Scheff; James R Pauly; Charles D Loftin
Journal:  BMC Neurosci       Date:  2009-08-31       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.